Innovations in eye health are among 17 ground-breaking medical projects that received AU$14.7 million in Federal Government funding in December 2019.
The Government is investing in these projects through the Medical Research Future Fund (MRFF), comprising $8.9 million through the BioMedTech Horizons (BMTH) program and more than $5.8 million through the Biomedical Translation Bridge (BTB) program. Funding for projects in eye health include:
Macuject Pty Ltd, Victoria, which is developing artificial intelligence-based clinical decision support software for intravitreal management of agerelated macular degeneration.
PolyActiva Pty Ltd, Victoria, which is developing sustained release ocular implants for delivery of steroids and non-steroidal anti-inflammatory medications to the eye for the prevention and treatment of macular oedema.
Enlighten Imaging Pty Ltd, Victoria, which is developing a novel hyperspectral retinal imaging platform for next generation artificial intelligence (AI) diagnostics.
The Australian National University, Australian Capital Territory, which has a team developing rapid and objective eye and brain testing for better management of ophthalmic and neurological diseases.
On 18 December the Federal Government announced a further $7.5 million in grants for research into AI in health care, which has been identified as one of the top three areas where Australia is well positioned to transform existing industries and build new ones, including opportunities to export solutions worldwide.